PRNewsWire
11 Oct 2026, 04:01 UTC · 4h ago
AnX Robotica Highlights Documented ProScan AI Workflow Performance from Submission to FDA
Impact · against what's priced in
AnX Robotica gains a significant competitive advantage as FDA filings reveal its ProScan AI reduces capsule review time by 88.6% (to 3m 50s), vastly outperforms a recently cleared competitor's 24.7% reduction (to 34.4m). The designation of ProScan as the primary predicate device further solidifies its position as the industry benchmark for AI-assisted endoscopy.
Scored by the NIS engine · methodology.
Search tags
